UPDATE: UBS Starts Concert Pharmaceuticals (CNCE) at Buy
Tweet Send to a Friend
(Updated - March 10, 2014 11:37 AM EDT)
UBS initiated coverage on Concert Pharmaceuticals (NASDAQ: CNCE) with a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
UBS initiated coverage on Concert Pharmaceuticals (NASDAQ: CNCE) with a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
